2026-01-21 - Analysis Report
**Company Overview (in 1 line)**
Northrop Grumman is a leading global security company and prime defence contractor.

**Return Rate Comparison**
Comparison of Northrop Grumman (NOC) return rate with S&P 500 (VOO).
- Cumulative return of review stock: 57.79%
- Cumulative return of comparison stock (S&P 500, VOO): 89.37%
- Divergence: -33.20 (difference in cumulative return on the last day of the data)
- Relative divergence: 24.70% (indicating current position in the past data)

**Alpha, Beta Analysis**
| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | -6.0% | 23.7% | -11.0% | 0.7 | 35.1B |
| 2017-2019  | 15.0% | 23.7% | -2.0% | 0.7 | 49.2B |
| 2018-2020  | -25.0% | 23.7% | -46.0% | 0.8 | 43.6B |
| 2019-2021  | 40.0% | 12.9% | -3.0% | 0.7 | 55.4B |
| 2020-2022  | 18.0% | 16.9% | 19.0% | 0.6 | 78.1B |
| 2021-2023  | 23.0% | 16.9% | 22.0% | 0.3 | 67.0B |
| 2022-2024  | -14.0% | 16.9% | -33.0% | 0.3 | 67.2B |
| 2023-2025  | -1.0% | 17.7% | -63.0% | 0.1 | 81.6B |

**Recent Stock Price Fluctuations**
- Close: $657.30
- 5-day SMA: $651.49
- 20-day SMA: $604.82
- 60-day SMA: $580.37
- Last-market: {'price': 657.3, 'previousClose': 666.9, 'change': -1.44} 

**RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence, Expected_Return**
- Market Risk Indicator (MRI): 0.80 (0.9~1.0: High Investment Recommended, 0.7~0.9: Medium Investment, 0.4~0.7: Low Investment, <0.4: Very Risky)
- RSI: 70.91
- PPO: 1.15
- Hybrid Signal: Buy
- Risk Level: Medium
- Recent (20 days) relative divergence change: +11.40 (improving)
- 7-day Rank change: +36 (rank up)
- 7-day Dynamic Expected Return change: +6.40 (improving)
- Expected Return (%): -39.90 (Expected excess return compared to S&P 500 if invested long-term)

**Recent News & Significant Events**
- [2026-01-20] Northrop Grumman (NOC) Projected to Post Quarterly Earnings on Tuesday - MarketBeat (news.google.com)
- [2026-01-08] Whatâ€™s The Risk For Northrop Grumman Stock As Trump Curbs Dividends And Executive Pay? - Forbes (news.google.com)
- [2026-01-08] Stocks making the biggest moves premarket: Lockheed Martin, Northrop Grumman, Gap, Alcoa & more - CNBC (news.google.com)
- [2026-01-15] Northrop Grumman Stock Hits All-Time High, Gets Rating Upgrade - Investor's Business Daily (news.google.com)
- [2026-01-08] Why Northrop Grumman (NOC) Stock Is Up Today - Finviz (news.google.com)
- [2026-01-13] Northrop Grumman: $1.5 Trillion Defense Budget Boosts F/A-XX Win (Rating Upgrade) - Seeking Alpha (news.google.com)

**Analyst Opinions**
- Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.17 (~Buy)
- Opinions: 21
- Target Price (avg/high/low): $673.72 / $777.00 / $576.00

**Recent Earnings Analysis**
| Date | EPS | Revenue |
|---|---:|---:|
| 2025-10-21 | 7.69 | 10.42 B$ |
| 2025-07-22 | 8.17 | 10.35 B$ |
| 2025-04-22 | 3.33 | 9.47 B$ |
| 2024-10-24 | 7.02 | 10.00 B$ |

**Financial Information**
Revenue and Profitability:
| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $10.42B | 21.37% |
| 2025-06-30 | $10.35B | 21.35% |
| 2025-03-31 | $9.47B | 16.69% |
| 2024-12-31 | $10.69B | 18.08% |
| 2024-09-30 | $10.00B | 21.07% |

Capital and Profitability:
| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $15.99B | 6.88% |
| 2025-06-30 | $15.47B | 7.59% |
| 2025-03-31 | $14.98B | 3.21% |
| 2024-12-31 | $15.29B | 8.27% |
| 2024-09-30 | $14.75B | 6.96% |

**Comprehensive Analysis**
- Northrop Grumman's return rate is lower than the S&P 500, with a cumulative return of 57.79% compared to 89.37% for the S&P 500.
- The Alpha, Beta analysis shows varying results across different periods, but generally indicates a lower return compared to the S&P 500.
- The recent stock price fluctuations indicate a decline in the stock price over the last 5-day period.
- The RSI, PPO index indicators and Delta_Previous_Relative_Divergence, Expected_Return indicate a medium risk level and a negative expected return.
- The recent news and significant events highlight the company's performance and market movements.
- The analyst opinions indicate a buy recommendation with a target price of $673.72.
- The recent earnings analysis shows varying results across different quarters, but generally indicates a higher revenue and profit margin compared to previous periods.
- The financial information indicates a higher revenue and profit margin compared to previous periods, but a lower equity and ROE.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.